Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Coronaviruses
  4. Volume 6, Issue 1
  5. Article
Volume 6, Issue 1
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Background

Computerized Tomography (CT) was extensively used in the COVID-19 era to confirm the diagnosis and follow the patient's response. The vaccine was rapidly introduced to break the disease chain of infection. The current study primarily aimed to examine the relationship between vaccination status and pulmonary CT findings. Moreover, it also aimed to validate the role of CT scan along with other patient criteria in predicting disease outcomes.

Methods

A retrospective cohort study was conducted at the radiology department of two Iraqi hospitals in Baghdad. The study enrolled all hospitalized patients with a confirmed COVID-19 diagnosis older than 18 years old. Their data regarding demographic criteria, vaccination criteria (the status and types), and radiological CT-scan parameters (including CT finding and severity score index) were collected.

Results

It was found that 23 percent of COVID-19 patients were immunized. Most of the unvaccinated cases were older than 45 years and were females. There was a significant correlation between the degree and severity of lung involvement and the vaccination status ( < 0.001). The worst radiological sign for severity was the ground glass appearance. The vaccine type showed significant changes in chest CT. Pfizer had the worst severity score, followed by Sinopharm in vaccinated cases. The overall mortality was 4.5%. Moreover, the vaccine significantly reduced mortality among vaccinated non-vaccinated cases ( = 0.03). By logistic regression, the CT score reliably predicted mortality with an odds ratio of 1.31 (1.18 to 1.45; < 0.001).

Conclusion

Vaccines were found to be significantly effective in protecting vaccinated people against severe infection and limiting lung injury, as evidenced by CT scores. Vaccines had a trend effect on reducing mortality. Moreover, CT scores were reliable in predicting the disease outcome.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975315612240425074611
2024-04-29
2025-01-06

  • From This Site

    /content/journals/covid/10.2174/0126667975315612240425074611
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ShiraniF. ShayganfarA. HajiahmadiS. COVID-19 pneumonia: A pictorial review of CT findings and differential diagnosis.Egypt. J. Radiol. Nucl. Med.20215213810.1186/s43055‑021‑00415‑2
     [Google Scholar]
  2. AkramN.N. IbrahimB.A. AliS.M. Clinical and laboratory characteristics of children with neurological presentations of COVID-19: A single-center experience.J. Med. Life2022151012941298
     [Google Scholar]
  3. MehtaO.P. BhandariP. RautA. KacimiS.E.O. HuyN.T. Coronavirus Disease (COVID-19): Comprehensive review of clinical presentation.Front. Public Health2021858293210.3389/fpubh.2020.582932 33520910
     [Google Scholar]
  4. DiamondM.S. KannegantiT.D. Innate immunity: The first line of defense against SARS-CoV-2.Nat. Immunol.202223210.1038/s41590‑021‑01091‑0
     [Google Scholar]
  5. MontazersahebS. KhatibiH.S.M. HejaziM.S. COVID-19 infection: An overview on cytokine storm and related interventions.Virol. J.202219110.1186/s12985‑022‑01814‑1
     [Google Scholar]
  6. CrombéA. BensidL. SeuxM. Impact of vaccination and the omicron variant on COVID-19–related chest CT findings: A multicenter study.Radiology20233073e22273010.1148/radiol.222730 36880948
     [Google Scholar]
  7. AudaI.G. OudahJ.G. SalihR.H. SARS-CoV-2 and other coronaviruses: A matter of variations.Al-Kindy Col Med J202319151010.47723/kcmj.v19i1.927
     [Google Scholar]
  8. KlugarM. RiadA. MekhemarM. Side effects of mRNA-based and viral vector-based COVID-19 vaccines among german healthcare workers.Biology20211075210.3390/biology10080752
     [Google Scholar]
  9. Abdel-QaderD.H. Abdel-QaderH. SilverthorneJ. Real-world effectiveness of four types of COVID-19 vaccines.Vaccines202311598510.3390/vaccines11050985 37243089
     [Google Scholar]
  10. Al-QeremW. HammadA. AlsajriA.H. Al-HishmaS.W. LingJ. MoslehR. COVID-19 vaccination acceptance and its associated factors among the Iraqi population: A cross sectional study.Patient Prefer. Adherence20221630731910.2147/PPA.S350917 35153477
     [Google Scholar]
  11. AkramN.N. NoriW. Al QaissiK.W. Multi-systemic inflammatory syndrome in childhood (MIS-C): A review article.J. Pak. Med. Assoc.202171S9S70S73
     [Google Scholar]
  12. SoheiliM. KhateriS. MoradpourF. The efficacy and effectiveness of COVID-19 vaccines around the world: A mini-review and meta-analysis.Ann. Clin. Microbiol. Antimicrob.20232214210.1186/s12941‑023‑00594‑y 37208749
     [Google Scholar]
  13. GaoY.D. DingM. DongX. Risk factors for severe and critically ill COVID-19 patients.A review. Allergy2021762428455
     [Google Scholar]
  14. NoriW. ZghairG.M.A. Omicron targets upper airways in pediatrics, elderly and unvaccinated population.World J. Clin. Cases20221032120621206510.12998/wjcc.v10.i32.12062 36405264
     [Google Scholar]
  15. MasciG.M. IzzoA. BonitoG. Chest CT features of COVID-19 in vaccinated versus unvaccinated patients: Use of CT severity score and outcome analysis.Radiol. Med.2023128893494310.1007/s11547‑023‑01664‑z 37354309
     [Google Scholar]
  16. Al-MosaweA.M. AbdulwahidH. FayadhN.A.H. Spectrum of CT appearance and CT severity index of COVID-19 pulmonary infection in correlation with age, sex, and PCR test: an Iraqi experience.Egypt. J. Radiol. Nucl. Med.20215214010.1186/s43055‑021‑00422‑3
     [Google Scholar]
  17. SharifP.M. NematizadehM. SaghazadehM. Computed tomography scan in COVID-19: A systematic review and meta-analysis.Pol. J. Radiol.2022871e1e23
     [Google Scholar]
  18. BautistaH.P.F. MuñizG.C. GaytánC.D.A. Impact of vaccination on infection or death from COVID-19 in individuals with laboratory-confirmed cases: Case-control study.PLoS One2023188e0265698
     [Google Scholar]
  19. KimM.S. KimJ.H. RyuS. Comparative efficacy and optimal duration of first-line antibiotic regimens for acute otitis media in children and adolescents: A systematic review and network meta-analysis of 89 randomized clinical trials.World J. Pediatr.202320321922910.1007/s12519‑023‑00716‑8 37016201
     [Google Scholar]
  20. AliM.U. ZafarA. TanveerJ. Deep learning network selection and optimized information fusion for enhanced COVID ‐19 detection.Int. J. Imaging Syst. Technol.2024342e2300110.1002/ima.23001
     [Google Scholar]
  21. LuW. YonD.K. LeeS.W. Safety of early surgery in hip fracture patients taking clopidogrel and/or aspirin: A systematic review and meta-analysis.J. Arthroplasty20235391374138310.1016/j.arth.2023.11.012 37972664
     [Google Scholar]
  22. OhY. JungY.J. SujataP. Spin in randomized controlled trials of pharmacology in COVID-19: A systematic review.Account. Res.2023202311910.1080/08989621.2023.2269083 37818630
     [Google Scholar]
  23. LeeM.H. LiH.J. WasuwanichP. COVID‐19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta‐analysis.Rev. Med. Virol.2023332e241410.1002/rmv.2414 36504172
     [Google Scholar]
  24. ChoK. ParkS. KimE.Y. Immunogenicity of COVID‐19 vaccines in patients with diverse health conditions: A comprehensive systematic review.J. Med. Virol.20229494144415510.1002/jmv.27828 35567325
     [Google Scholar]
  25. MarchandG. MasoudA.T. MediS. Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies.Hum. Vaccin. Immunother.2023192223082810.1080/21645515.2023.2230828
     [Google Scholar]
  26. ChengH. PengZ. LuoW. Efficacy and safety of COVID-19 vaccines in phase iii trials: A meta-analysis.Vaccines20219658210.3390/vaccines9060582 34206032
     [Google Scholar]
  27. FeketeM. HorvathA. SantaB. TomisaG. SzollosiG. VargaJ.T. First booster dose uptake of COVID-19 vaccine and disease-related factors in chronic obstructive pulmonary disease—a cross-sectional survey in Hungary.Ann. Palliat. Med.202312351652810.21037/apm‑22‑1256 37038057
     [Google Scholar]
  28. SamirA. AltarawyD. SweedR.A. Abdel-KerimA.A. “Sinopharm”, “Oxford-AstraZeneca”, and “Pfizer-BioNTech” COVID-19 vaccinations: Testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA).Egypt. J. Radiol. Nucl. Med.20235415310.1186/s43055‑023‑00999‑x
     [Google Scholar]
  29. NoriW. AkramW. Effect of gender on the reliability of COVID-19 rapid antigen test among elderly.World J. Clin. Cases20221029108201082210.12998/wjcc.v10.i29.10820 36312479
     [Google Scholar]
  30. AliD.M. ZakeL.G. El KadyN.K. Role of chest computed tomography versus real time reverse transcription polymerase chain reaction for diagnosis of COVID-19: A systematic review and meta-analysis.Interdiscip. Perspect. Infect. Dis.2021202111210.1155/2021/8798575 34194491
     [Google Scholar]
  31. ParekhM. DonuruA. BalasubramanyaR. KapurS. Review of the chest CT differential diagnosis of ground-glass opacities in the COVID era.Radiology20202973E289E30210.1148/radiol.2020202504 32633678
     [Google Scholar]
  32. MoradiB. GhanaatiH. KazemiM.A. Implications of sex difference in ct scan findings and outcome of patients with covid-19 pneumonia.Radiol. Cardiothorac. Imaging202024e20024810.1148/ryct.2020200248 33778607
     [Google Scholar]
  33. NoriW. Akeel SalmanD. Seminal fluid changes in the COVID-19 era: During infection and Post-vaccination.Gynecology and Obstetrics Clinical Medicine202332889310.1016/j.gocm.2023.04.001 38620126
     [Google Scholar]
  34. PourhoseingholiM.A. VahediM. RahimzadehM. Sample size calculation in medical studies.Gastroenterol. Hepatol. Bed Bench2013611417 24834239
     [Google Scholar]
  35. HallV.J. FoulkesS. SaeiA. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): A prospective, multicentre, cohort study.Lancet2021397102861725173510.1016/S0140‑6736(21)00790‑X
     [Google Scholar]
  36. MuellerA.L. McNamaraM.S. SinclairD.A. Why does COVID-19 disproportionately affect older people?Aging202012109959998110.18632/aging.103344 32470948
     [Google Scholar]
  37. JinJ.M. BaiP. HeW. Gender differences in patients with COVID-19: Focus on severity and mortality.Front. Public Health2020815210.3389/fpubh.2020.00152 32411652
     [Google Scholar]
  38. BorghesiA. ZiglianiA. MasciulloR. Radiographic severity index in COVID-19 pneumonia: Relationship to age and sex in 783 Italian patients.Radiol. Med.2020125546146410.1007/s11547‑020‑01202‑1
     [Google Scholar]
  39. TahirA.I. RamadhanD.S. PiroS.S. AbdullahR.Y. TahaA.A. RadhaR.H. COVID-19 vaccine acceptance, hesitancy and refusal among Iraqi Kurdish population.Int. J. Health Sci.20221611016 35024029
     [Google Scholar]
  40. DarweeshO. KhatabN. KhederR. Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.PLoS One20221711e027452610.1371/journal.pone.0274526
     [Google Scholar]
  41. KazzazH.A.H. COVID19 vaccination choice among Iraqi students at Al-Zahraa University for women.F1000 Res.202110101510.12688/f1000research.55552.1 35903215
     [Google Scholar]
  42. ForraiG. KovácsE. AmbrózayÉ. Use of diagnostic imaging modalities in modern screening, diagnostics and management of breast tumours 1st central-eastern European professional consensus statement on breast cancer.Pathol. Oncol. Res.202228161038210.3389/pore.2022.1610382 35755417
     [Google Scholar]
  43. AkramN.N. JaafarM.M. AbdulqaderS.K. Clinical characteristics and therapeutic management of osteogenesis imperfecta in iraqi children.Al-Rafidain J Med Sci20235S1S189S19410.54133/ajms.v5i1S.416
     [Google Scholar]
  44. VishwanathT. RajalakshmiB. SadanandaK. Association of chest CT severity scores and vaccination status in COVID-19 disease: A cross-sectional study.In: J Clin Diag Res.2022162TC172010.7860/JCDR/2022/51686.16027
     [Google Scholar]
  45. SalaffiF. CarottiM. TardellaM. The role of a chest computed tomography severity score in coronavirus disease 2019 pneumonia.Medicine2020994210.1097/MD.0000000000022433
     [Google Scholar]
  46. OmarS. MotaweaA.M. YasinR. High-resolution CT features of COVID-19 pneumonia in confirmed cases.Egypt. J. Radiol. Nucl. Med.202051112110.1186/s43055‑020‑00236‑9
     [Google Scholar]
  47. TiefenbrunL.M. YelinI. KatzR. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine.Nat. Med.202127510.1038/s41591‑021‑01316‑7
     [Google Scholar]
  48. SinghS. AhujaA. RamankuttyR. RamaswamyS. COVID-19: Different strains of corona, vaccine efficacy, treatment, medical ethics, and future perspectives.Coronaviruses202344e20102322247410.2174/0126667975265095231019065626
     [Google Scholar]
  49. LaiM. WangK. DingC. Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients.Ann. Clin. Microbiol. Antimicrob.20232212210.1186/s12941‑023‑00569‑z
     [Google Scholar]
  50. SaintonJ. Criticism of the HAS opinion of July 21st, 2022, on maintaining of the SARS-Cov-2 vaccine mandate for healthcare workers.Coronaviruses202342e04082321943210.2174/2666796704666230804103419
     [Google Scholar]
  51. CaoL. LouJ. ChanS.Y. Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance.Nat. Med.202228810.1038/s41591‑022‑01877‑1
     [Google Scholar]
  52. RabaanA.A. Al-AhmedS.H. AlbayatH. Variants of SARS-CoV-2: Influences on the vaccines’ effectiveness and possible strategies to overcome their consequences.Medicina20235950710.3390/medicina59030507
     [Google Scholar]
  53. ChamorroM.E. TascónD.A. SanzI.L. VélezO.S. NacentaB.S. Diagnóstico radiológico del paciente con COVID-19.Radiologia2021631567310.1016/j.rx.2020.11.001
     [Google Scholar]
  54. SzabóM. KardosZ. KostyálL. The importance of chest CT severity score and lung CT patterns in risk assessment in COVID-19-associated pneumonia: A comparative study.Front. Med.202310112553010.3389/fmed.2023.1125530 37265487
     [Google Scholar]
  55. AbdulqaderS.K. AliF.F.A. BakrG.M. Cohort comparative study of COVID-19 vaccinated and non-vaccinated patients depending on CT chest findings between Iraqi and Jordanian population.Russian Electr J Radiol202414151510.21569/2222‑7415‑2024‑14‑1‑5‑15
     [Google Scholar]
/content/journals/covid/10.2174/0126667975315612240425074611
Loading
Impact of Vaccination Status on Chest CT Findings and Disease Outcomes in COVID-19 Era: A Retrospective Study
Coronaviruses 6, E290424229477 (2025); https://doi.org/10.2174/0126667975315612240425074611
/content/journals/covid/10.2174/0126667975315612240425074611
/content/journals/covid/10.2174/0126667975315612240425074611
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): COVID-19; CT scan; CT severity score; mortality; pneumonia; Vaccines
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test